DCM
CRDF icon

DAFNA Capital Management’s Cardiff Oncology CRDF Stock Holding History

DAFNA Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-150,000
Closed -$471K – 77
2025
Q1 		$471K Buy
+150,000
New +$593K 0.13% 70
2020
Q4 		– Sell
-5,000
Closed -$71K – 80
2020
Q3 		$71K Buy
+5,000
New +$33K 0.02% 80

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DAFNA Capital Management's CRDF Position: Q2 2025 in Review

DAFNA Capital Management sold out of Cardiff Oncology (CRDF) in Q2 2025, closing a stake of 150,000 shares — an estimated $471K sold.

DAFNA Capital Management first reported a position in CRDF in Q3 2020 and held it in 2 quarters. The position peaked at $471K in Q1 2025. 114 funds tracked by Wall St. Rank hold CRDF as of Q2 2025.

  • DAFNA Capital Management reported no remaining Cardiff Oncology position as of Q2 2025 after selling out during the quarter.
  • DAFNA Capital Management sold 150,000 Cardiff Oncology shares in Q2 2025, an estimated $471K.
  • DAFNA Capital Management first reported a position in Cardiff Oncology in Q3 2020 and held it in 2 quarters.
  • DAFNA Capital Management's Cardiff Oncology position peaked at $471K in Q1 2025.
  • 114 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2025.

Based on DAFNA Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.